Ebima Clifford Okundaye
Clinical trials sponsored by Ebima Clifford Okundaye, explained in plain language.
-
New drug QRX-3 aims to speed kidney recovery in hospital patients
Disease control Not yet recruitingThis study tests an investigational drug called QRX-3 in 500 hospitalized adults and children with acute kidney failure caused by tubular necrosis. The goal is to see if adding QRX-3 to standard care improves kidney function faster than placebo. Participants must have a confirmed…
Phase: PHASE2, PHASE3 • Sponsor: Ebima Clifford Okundaye • Aim: Disease control
Last updated May 15, 2026 11:53 UTC
-
New drug QRX3 could slow kidney decline in millions
Disease control Not yet recruitingThis study tests a new drug called QRX3 in 3000 people with chronic kidney disease (CKD) whose kidney function is declining. The goal is to see if QRX3 can improve kidney function and slow further damage. Participants will take the drug and have their kidney function measured ove…
Phase: PHASE2, PHASE3 • Sponsor: Ebima Clifford Okundaye • Aim: Disease control
Last updated May 11, 2026 20:39 UTC